Importantly, we found that antibody-based blockade of Lcn2 reversed osteoporosis and marrow adiposity in Piezo1-deficient mice, suggesting that pharmacological/genetic inhibition of BMMSC-secreted Lcn2 may represent a promising pharmacotherapy for mechanical unloading-induced bone diseases. Here, LCN2 is linked to osteoporosis.